Sonal Mercantile (538943)
TurnaroundScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹102.9 |
| Market Cap | ₹151.66 Cr |
| P/E Ratio | 5.29 |
| ROCE | 5.69% |
| ROE | 14.31% |
| Dividend Yield | 0% |
| Profit Growth | -65.04% |
| Debt/Equity | — |
| Sales Growth | 0.36% |
| 52-Week Range | ₹78 — ₹153.33 |
| Sector | Finance |
| Book Value | ₹41 |
Strengths
- P/E of 5.29 is statistically low, offering an earnings yield of roughly 19% if the reported profit is maintained.
- ROE of 14.31% is respectable for a small lender.
- Latest quarter sales of ₹8 Cr and net profit of ₹3 Cr show the business is still profitable.
- Price at ₹102.90 is well below the 52-week high of ₹153.33, so expectations do not appear excessive.
Concerns
- Profit growth is -65.04% while sales growth is only 0.36%, indicating a severe deterioration in earnings.
- Piotroski F-Score of 4/9 and PEG of 14.69 suggest weak financial health and poor growth-adjusted valuation.
- P/B of 2.51 means paying more than 2.5 times the ₹41 book value, while ROCE is a thin 5.69%.
- No dividend and no promoter holding disclosure leave minority shareholders without cash return or governance clarity.
AI Analysis
As I read the numbers for Sonal Mercantile, my first thought is caution, not excitement. This is a small NBFC with a market cap of ₹152 Cr, and in my experience small lenders rarely possess a durable moat. The price of ₹102.90 gives a P/E of only 5.29, but a low multiple is nothing if earnings are collapsing. Sales growth is just 0.36%, while profit growth is -65.04%. The PEG ratio of 14.69 tells me the market isn't pricing in meaningful growth, and neither am I. The Piotroski score of 4 out of 9 reinforces the suspicion that the financial health is poor. I am being asked to pay 2.51 times book value of ₹41, yet the business earns a ROCE of only 5.69%. ROE of 14.31% is respectable, but without leverage data and with no dividend, I can't verify how that return is being generated or whether it is sustainable. The latest quarter shows sales of ₹8 Cr and net profit of ₹3 Cr, which looks positive, but one quarter doesn't undo a 65% profit decline. Mr. Market has given this a wide range in the past year, from ₹78 to ₹153.33, so volatility is high. As Graham would say, price is what you pay, value is what you get. Here, I cannot see enough value. A 2.5 times book valuation for a stagnant, small lender with a weak Piotroski score does not give me a margin of safety. I need evidence that the profit slide has reversed, better disclosure on promoter holding and leverage, and a clear reason to believe the business can compound capital. Until then, this is a pass. I prefer to wait for a wonderful business at a fair price, or at least a mediocre business at a genuinely cheap price.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer